To investigate the role of CAV1 in MASLD, we fed eight-week-old wild-type (WT) and CAV1-KO mice NCD or HFD for 16 weeks (Fig. 2A). Here, CAV1 is linked to metabolic dysfunction-associated steatotic liver disease.